Skip to main content
OpenTrials

Clinical trial condition

Endometrial Carcinoma

Explore clinical trials studying Endometrial Carcinoma. Study availability and eligibility vary by location and protocol.

80 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Carcinoma trial results

Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

NCT05256225

Conditions
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
View all 414 locations
View Trial Details
Recruiting

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

NCT07216105

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
  • Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States
  • M. D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NCT04851119

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +90 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 21 locations
View Trial Details
Recruiting

FOG-001 in Locally Advanced or Metastatic Solid Tumors

NCT05919264

Conditions
Adamantinomatous Craniopharyngioma, Adenocarcinoma, Adenoma, +65 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • Arizona Cancer Center at University of Arizona Tucson, Arizona, United States
  • University of California, Los Angeles (UCLA) Los Angeles, California, United States
View all 33 locations
View Trial Details
Recruiting

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

NCT07741968

Conditions
Adnexal Diseases, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, +44 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • City of Hope at Arcadia Arcadia, California, United States
  • City of Hope at Seacliff Huntington Beach, California, United States
View Trial Details

Related conditions